Cristiana M. Grapa

Cluj-napoca, CJ 400162, Romania

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

CRAFITY and PALBI Define a Machine Learning-Supported Prognostic Framework in Hepatocellular Carcinoma-Data from an Eastern European Cohort with Low Macrotrabecular-Massive Prevalence.

CRAFITY and PALBI Define a Machine Learning-Supported Prognostic Framework in Hepatocellular Carcinoma-Data from an Eastern European Cohort with Low Macrotrabecular-Massive Prevalence.

Journal: Diseases (Basel, Switzerland)

Published: June 08, 2026

AI-guided additive scoring model for differential diagnosis of primary liver cancer.

AI-guided additive scoring model for differential diagnosis of primary liver cancer.

Journal: JHEP reports : innovation in hepatology

Published: October 23, 2025

Turning the Tide-Artificial Intelligence in the Evolving Landscape of Liver Cancer.

Turning the Tide-Artificial Intelligence in the Evolving Landscape of Liver Cancer.

Journal: Cancers

Published: August 06, 2025

Sarcopenia in MASLD-Eat to Beat Steatosis, Move to Prove Strength.

Sarcopenia in MASLD-Eat to Beat Steatosis, Move to Prove Strength.

Journal: Nutrients

Published: November 23, 2024

The Bleeding Edge: Managing Coagulation and Bleeding Risk in Patients with Cirrhosis Undergoing Interventional Procedures.

The Bleeding Edge: Managing Coagulation and Bleeding Risk in Patients with Cirrhosis Undergoing Interventional Procedures.

Journal: Diagnostics (Basel, Switzerland)

Published: October 28, 2024

Cirrhosis Progression Is Not Associated with Clinically Significant Alterations in Global Hemostasis Assessed by Thromboelastography.

Cirrhosis Progression Is Not Associated with Clinically Significant Alterations in Global Hemostasis Assessed by Thromboelastography.

Journal: Journal of clinical medicine

Published: September 03, 2024

Unveiling novel serum biomarkers in intrahepatic cholangiocarcinoma: a pilot proteomic exploration.

Unveiling novel serum biomarkers in intrahepatic cholangiocarcinoma: a pilot proteomic exploration.

Journal: Frontiers in pharmacology

Published: May 30, 2024

Unveiling Health Inequalities: Exploring Metabolic Dysfunction in Rural Roma Communities.

Unveiling Health Inequalities: Exploring Metabolic Dysfunction in Rural Roma Communities.

Journal: Healthcare (Basel, Switzerland)

Published: February 28, 2024

Increased type-I interferon level is associated with liver damage and fibrosis in primary sclerosing cholangitis.

Increased type-I interferon level is associated with liver damage and fibrosis in primary sclerosing cholangitis.

Journal: Hepatology communications

Published: October 17, 2023

Don't Judge a Book by Its Cover: The Role of Statins in Liver Cancer.

Don't Judge a Book by Its Cover: The Role of Statins in Liver Cancer.

Journal: Cancers

Published: August 29, 2023

PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for patients with intrahepatic cholangiocarcinoma.

PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for patients with intrahepatic cholangiocarcinoma.

Journal: Cancer immunology, immunotherapy : CII

Published: August 19, 2022

Carbon Nanotubes-Based Assays for Cancer Detection and Screening.

Carbon Nanotubes-Based Assays for Cancer Detection and Screening.

Journal: Pharmaceutics

Published: February 09, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026